American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism
In August 2022, these guidelines were reviewed by an expert work group convened by ASH.
Review included limited searches for new evidence and discussion of the search results …
Review included limited searches for new evidence and discussion of the search results …
2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS) The …
SV Konstantinides, G Meyer, C Becattini… - European heart …, 2020 - academic.oup.com
determination and the implementation of preventive, diagnostic or therapeutic medical
strategies. However, the ESC Guidelines do not override in any way whatsoever the …
strategies. However, the ESC Guidelines do not override in any way whatsoever the …
Antithrombotic therapy for VTE disease: second update of the CHEST guideline and expert panel report
Background This is the 2nd update to the 9th edition of these guidelines. We provide
recommendations on 17 PICO (Population, Intervention, Comparator, Outcome) questions …
recommendations on 17 PICO (Population, Intervention, Comparator, Outcome) questions …
Editor's Choice–European Society for Vascular Surgery (ESVS) 2021 clinical practice guidelines on the management of venous thrombosis
SK Kakkos, M Gohel, N Baekgaard… - European Journal of …, 2021 - ejves.com
2.1. 1. Epidemiology and burden of the disease. The annual incidence of first episode of
symptomatic DVT in the adult population ranges from 50 to 100 per 100 000 population, with …
symptomatic DVT in the adult population ranges from 50 to 100 per 100 000 population, with …
Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report
Background We update recommendations on 12 topics that were in the 9th edition of these
guidelines, and address 3 new topics. Methods We generate strong (Grade 1) and weak …
guidelines, and address 3 new topics. Methods We generate strong (Grade 1) and weak …
International consensus on the prevention of venous and arterial thrombotic events in patients with inflammatory bowel disease
Patients with inflammatory bowel disease (IBD) are at increased risk of thrombotic events.
Therapies for IBD have the potential to modulate this risk. The aims of this Evidence-Based …
Therapies for IBD have the potential to modulate this risk. The aims of this Evidence-Based …
Deep vein thrombosis and pulmonary embolism
M Di Nisio, N van Es, HR Büller - The Lancet, 2016 - thelancet.com
Deep vein thrombosis and pulmonary embolism, collectively referred to as venous
thromboembolism, constitute a major global burden of disease. The diagnostic work-up of …
thromboembolism, constitute a major global burden of disease. The diagnostic work-up of …
Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event …
Objectives To determine the rate of a first recurrent venous thromboembolism (VTE) event
after discontinuation of anticoagulant treatment in patients with a first episode of unprovoked …
after discontinuation of anticoagulant treatment in patients with a first episode of unprovoked …
Thrombophilia testing and venous thrombosis
JM Connors - New England Journal of Medicine, 2017 - Mass Medical Soc
Thrombophilia Testing and Venous Thrombosis | New England Journal of Medicine Skip to
main content Access provided by Charite - Universitaetsmedizin Berlin The New England …
main content Access provided by Charite - Universitaetsmedizin Berlin The New England …
Categorization of patients as having provoked or unprovoked venous thromboembolism: guidance from the SSC of ISTH
Whether an episode of venous thromboembolism (VTE) was unprovoked or provoked by an
environmental (or acquired) risk factor and, if it was provoked, whether the provoking factor …
environmental (or acquired) risk factor and, if it was provoked, whether the provoking factor …